Principal investigators (PIs) interviewed for a recent academic dissertation recognized the need for greater diversity among participants in the clinical trials they run but...
ARTICLE | FinancePlus: Stoke falls on Dravet update and updates from Astellas-PeptiDream, Kiniksa and A-Alpha By BioCentury Staff
July 26, 2023 12:38 AM UTC
As part of its “Fit...
Dive Brief:
Stoke Therapeutics on Tuesday revealed study results from a pair of small, mid-stage trials testing a medicine designed to target the underlying cause...
Cannabinoids are a class of over 60 chemical compounds in the cannabis plant. Here are included cannabinol (CBD) and tetrahydrocannabinol (THC) as the majorly...
A recently published Japanese study has yet again demonstrated CBD’s potential in epilepsy. This is the first study of this nature to be conducted in the...
Given the potential harm to a child's developing brain and the lack of available evidence, most Canadian pediatricians are reluctant to recommend medical cannabis...
BERWYN, Pa.–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...
